Form 4 for NAUT Nautilus Biotechnology, Inc.
Accepted 2021-08-16 00:00:00 ET · period of report 2021-08-12 · accession 0001808805-21-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-16 | 2021-08-12 | NAUT | Mowry Anna | CFO, Treas | P - Purchase | $7.71 | +17.5K | 17.5K | New | +$134.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-12 | P | A | 17,500 | $7.71 | 17,500 | D | — | — | (F1) Represents the weighted average share price of an aggregate total of 17,500 shares purchased in the price range of $7.60 to $7.73 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |